Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

NCT00253526 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Stage I Pancreatic Cancer
Stage II Pancreatic Cancer
Stage III Pancreatic Cancer

Interventions

DRUG: bevacizumab
DRUG: gemcitabine hydrochloride
PROCEDURE: adjuvant therapy
PROCEDURE: anti-cytokine therapy
PROCEDURE: antiangiogenesis therapy
PROCEDURE: antibody therapy
PROCEDURE: biological therapy
PROCEDURE: chemotherapy
PROCEDURE: conventional surgery
PROCEDURE: growth factor antagonist therapy
PROCEDURE: monoclonal antibody therapy
PROCEDURE: surgery

Sponsor

National Cancer Institute (NCI)